Author

Karine Leclercq

UCB Pharma (Belgium)ORCID 0000-0002-5522-9596Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrée Delahaye‐DurieziD· 1 shared Bénédicte Danis· 1 shared Catherine Vandenplas· 1 shared Enrico G. PetrettoiD· 1 shared Frederic Vanclef· 1 shared Georges Mairet‐Coello· 1 shared Jonathan M. van EylliD· 1 shared Kirill ShkuraiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Andrée Delahaye‐DuriezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Systems-Level Framework For Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target

Prashant Kumar Srivastava, Jonathan M. van Eyll, Patrice Godard, Manuela Mazzuferi, Bénédicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet‐Coello, Frederic Vanclef, Kirill Shkura, Liisi Laaniste, Andrée Delahaye‐Duriez, Rafal Marian Kaminski, Enrico G. Petretto, Michael R. Johnson

This paper introduces CRAFT, a computational framework for drug target identification, and validates Csf1R as a novel anti-epileptic target using pre-clinical models.

bioRxiv · May 22, 2017 · PreprintSystems Biology